Entry Rationale
Considering the extreme oversold conditions and the price range near the support level, it is time to approach with a staggered buying strategy, keeping the possibility of a short-term rebound open.
Baker Hughes non-GAAP EPS of $0.64 beats by $0.15, revenue of $6.74B beats by $230M
Baker Hughes' non-GAAP EPS and revenue both exceeded expectations, serving as a positive performance catalyst for the market.
Considering the extreme oversold conditions and the price range near the support level, it is time to approach with a staggered buying strategy, keeping the possibility of a short-term rebound open.
After confirming support in the extreme oversold range of an RSI of 9.8, I aim for a short-term rebound. I will take profits upon reaching the target price of $60.0, and if the support level of $55.0 breaks, I will cut losses.
The RSI(14) is at a level of 9.8, indicating an extreme oversold condition.
Based on the extreme oversold condition of an RSI of 9.8 at the time of prediction and the price movement near the support level, a short-term rebound was anticipated. The actual result significantly exceeded the predicted return of 2.5%, achieving a return of 11.4%, resulting in an OVERHIT designation. Along with the earnings surprise, subsequent developments such as large-scale orders and being selected as an analyst top pick appear to have collectively contributed to a much stronger upward momentum than expected.
Through this transaction, we confirmed the validity of a technical rebound in an extremely oversold condition. However, we will keep in mind that if additional news or contract announcements provide further momentum, profits could significantly increase. In future similar oversold phases, rather than liquidating all positions upon reaching the target price, we will complement our strategy by flexibly assessing the presence of additional positive factors.